People with type 2 diabetes are at risk of blood cancer
People with type 2 diabetes are more likely to suffer from blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new research.
Researchers analyzed a connection between type 2 diabetes and the incidence of lymphoma, leukemia and myeloma. The meta-analysis included more than 17,000 cases of type 2 diabetes and blood cancer around the world.
They made a conclusion that patients with type 2 diabetes have an increased risk of developing leukemia, myeloma and non-Hodgkin lymphoma, as well as a subtype of non-Hodgkin lymphoma known as peripheral T-cell lymphoma. They did not find any associations with Hodgkin lymphoma.
Researchers consider that type 2 diabetes could be connected with nearly 5% of all incidents of leukemia, myeloma non-Hodgkin lymphoma. In addition, the odds of lymphoma, leukemia and myeloma depend on the geographic region. For instance, the risk of non-Hodgkin lymphoma was higher in Asia and Europe, while there was an increased leukemia risk in the United States and Asia.
Further studies are needed to explain the potential relationship between type 2 diabetes and blood cancers. Future researches should focus on the role of behavioral factors like obesity, physical activity and smoking, which have been linked to both diabetes and cancer.